Nuveen »

Bridgebio Oncology Therapeut shares owned by Nuveen

Quarter-by-quarter ownership of Bridgebio Oncology Therapeut (BBOT) shares owned by Nuveen from 13F filings

Historical chart of Nuveen investment in Bridgebio Oncology Therapeut

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Oncology Therapeut held by Nuveen consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Oncology Therapeut by Nuveen

Quarter filed Position value Share count Share price at filing
2026-09-30 $3.8k 960 3.92

More positions owned by Nuveen

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Micron Technology (MU)
Eli Lilly & Co. (LLY)
Advanced Micro Devices (AMD)
Tesla Motors (TSLA)
JPMorgan Chase & Co. (JPM)
Mastercard Incorporated Cl A (MA)
Nush Etf Tr Nuvee Aggre Etf (NXUS)

View all positions for Nuveen

Top funds holding Bridgebio Oncology Therapeut

Cormorant Asset Management
Deerfield Management Company
Omega Fund Management
Alphabet
EcoR1 Capital
Wellington Management Company
Enavate Sciences GP
Citadel Advisors
Regents of the University of California
Novo A/S
BlackRock
Vanguard Capital Management
Laurion Capital Management
Armistice Capital
State Street Corporation

View all funds holding Bridgebio Oncology Therapeut